# Steven Fishbane

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/steven-fishbane/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,896 |
| Field | Erythropoietin and Anemia Treatment |
| h-index | 62 |
| i10-index | 136 |
| Last Known Institution | Northwell Health |
| OpenAlex ID | https://openalex.org/A5016502106 |
| ORCID iD | 0000-0002-2238-8574 |
| Works | 298 |

## Researcher papers

Showing 12 of 18.

- [Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients](https://scholariq.org/papers/targeting-hypoxia-inducible-factors-for-the-treatment-of-anemia-in-chronic/)
- [Acute kidney injury in patients hospitalized with COVID-19](https://scholariq.org/papers/acute-kidney-injury-in-patients-hospitalized-with-covid-19/)
- [Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies](https://scholariq.org/papers/prevalence-of-depression-in-chronic-kidney-disease-systematic-review-and-meta/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation](https://scholariq.org/papers/reduction-in-recombinant-human-erythropoietin-doses-by-the-use-of-chronic/)
- [A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus](https://scholariq.org/papers/a-phase-3-trial-of-difelikefalin-in-hemodialysis-patients-with-pruritus/)
- [Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management](https://scholariq.org/papers/hypersensitivity-reactions-to-intravenous-iron-guidance-for-risk-minimization/)
- [Outcomes of patients with end-stage kidney disease hospitalized with COVID-19](https://scholariq.org/papers/outcomes-of-patients-with-end-stage-kidney-disease-hospitalized-with-covid-19/)
- [Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018](https://scholariq.org/papers/update-on-anemia-in-esrd-and-earlier-stages-of-ckd-core-curriculum-2018/)
- [A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography](https://scholariq.org/papers/a-randomized-controlled-trial-of-n-acetylcysteine-to-prevent-contrast/)
- [Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury](https://scholariq.org/papers/outcomes-among-patients-hospitalized-with-covid-19-and-acute-kidney-injury/)
- [Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients](https://scholariq.org/papers/reticulocyte-hemoglobin-content-in-the-evaluation-of-iron-status-of-hemodialysis/)

## Researcher topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Researcher university

- [Northwell Health](https://scholariq.org/institutions/northwell-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.